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RESEARCH ARTICLE
Lifetime Smoking History and Cause-Specific
Mortality in a Cohort Study with 43 Years of
Follow-Up
Niloofar Taghizadeh1,2, Judith M. Vonk1,3, H. Marike Boezen1,3*
1 Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen,
the Netherlands, 2 Cumming School of Medicine, Division of Respiratory Medicine, University of Calgary,
Calgary, Alberta, Canada, 3 GRIAC Research Institute, University of Groningen, University Medical Centre




In general, smoking increases the risk of mortality. However, it is less clear how the relative
risk varies by cause of death. The exact impact of changes in smoking habits throughout life
on different mortality risks is less studied.
Methods
We studied the impact of baseline and lifetime smoking habits, and duration of smoking on
the risk of all-cause mortality, mortality of cardiovascular diseases (CVD), chronic obstruc-
tive pulmonary disease (COPD), any cancer and of the four most common types of cancer
(lung, colorectal, prostate, and breast cancer) in a cohort study (Vlagtwedde-Vlaardingen
1965–1990, with a follow-up on mortality status until 2009, n = 8,645). We used Cox regres-
sion models adjusted for age, BMI, sex, and place of residence. Since previous studies sug-
gested a potential effect modification of sex, we additionally stratified by sex and tested for
interactions. In addition, to determine which cause of death carried the highest risk we per-
formed competing-risk analyses on mortality due to CVD, cancer, COPD and other causes.
Results
Current smoking (light, moderate, and heavy cigarette smoking) and lifetime persistent
smoking were associated with an increased risk of all-cause, CVD, COPD, any cancer, and
lung cancer mortality. Higher numbers of pack years at baseline were associated with an
increased risk of all-cause, CVD, COPD, any cancer, lung, colorectal, and prostate cancer
mortality. Males who were lifetime persistent pipe/cigar smokers had a higher risk of lung
cancer [HR (95% CI) = 7.72 (1.72–34.75)] as well as all-cause and any cancer mortality. A
longer duration of smoking was associated with a higher risk of COPD, any and lung cancer
[HR (95% CI) = 1.06 (1.00–1.12), 1.03 (1.00–1.06) and 1.10 (1.03–1.17) respectively], but
not with other mortality causes. The competing risk analyses showed that ex- and current
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smokers had a higher risk of cancer, CVD, and COPDmortality compared to all other mor-
tality causes. In addition, heavy smokers had a higher risk for COPD mortality compared to
cancer, and CVDmortality.
Conclusion
Our study indicates that lifetime numbers of cigarettes smoked and the duration of smoking
have different impacts for different causes of mortality. Moreover, our findings emphasize
the importance of smoking-related competing risks when studying the smoking-related can-
cer mortality in a general population and that smoking cessation immediately effectively
reduces the risk of all-cause and any cancer mortality.
Introduction
Tobacco smoking has been clearly linked to the most common causes of death including can-
cer, cardiovascular disease (CVD), and COPD [1–3]. The association between cigarette smok-
ing and the development of these diseases has mainly been explained by the fact that smoking
causes a systemic oxidant-antioxidant imbalance and an inflammatory response [4].
Since 1950, many studies have shown that tobacco smoking is associated with an increased
risk of lung cancer [5]. In the first International Agency for Research on Cancer (IARC) Mono-
graph on tobacco smoking in 1986, not only lung cancer but also some other types of cancer
including cancer of upper aerodigestive tract, pancreas, and lower urinary tract were reported
to be associated with smoking [6]. Further studies on the association between smoking and dif-
ferent types of cancers added more cancer types to this list. In the second IARCMonograph on
tobacco smoking of 2004 [7] and the last monograph of 2012 [8], 14 other types of cancer were
listed as smoking-related cancers, e.g. cancers of the oral cavity, nasal cavity, stomach, liver,
kidney, cervix, and myeloid leukemia. However, for some other types of cancer such as prostate
and breast cancer still no conclusion on their association with smoking could be drawn across
the studies.
Most importantly, like for cancer, tobacco smoking is reported to cause nearly 10% of CVD
worldwide [9]. In addition, it has been estimated that 90% of all COPD mortality can be attrib-
uted to cigarette smoking [10]. Several prospective cohort studies have addressed the beneficial
effect of smoking cessation on CVD and COPDmortality [9,10].
Several studies have indicated that the association between smoking and mortality appears
to be different for different causes of death such as cancer, CVD, and COPD [2,11]. However,
the differences in this association with smoking between various causes of death (e.g. cancer
and CVD) have not been formally analyzed using statistical approaches such as competing risk
analyses. So far, the only previous study that statistically analyzed these differences was per-
formed solely on females [11]. Moreover, the majority of previous studies were based on smok-
ing habits at baseline and the level of detail on lifetime smoking history (e.g. regarding
duration of smoking and cessation) in these studies is limited. The disadvantage of relying on
baseline smoking habits is that the changes in smoking behavior during follow-up cannot be
tracked. One example of this behavior change is that baseline smoker may quit during follow-
up, therefore this group potentially includes progressively more quitters. Moreover, the results
of few studies on lifetime smoking history remain inconclusive. For instance, Vineis et al [12]
in a review reported that the beneficial effect of smoking cessation is the same for smoking-
related cancer and non-neoplastic disease, while Kenfield et al [11] suggested that benefits of
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smoking cessation vary by causes of death. Thus, more prospective investigations are needed to
determine the lifetime smoking-attributable risk of cause-specific mortality.
In addition, while the majority of studies indicated that females may be more susceptible to
the carcinogenic effects of smoking [12–14], little is known about the mechanisms explaining a
possible gender difference in the association between smoking and mortality.
Although smoking cigarettes is the most common form of tobacco usage, pipe/cigar smoking
also accounts for a considerable proportion of tobacco smokers in some countries. For instance,
in the European Prospective Investigation into Cancer (EPIC) study of 500,000 subjects across 10
countries, more than 3,500 males were exclusively pipe/cigar smokers, and 15,000 males smoked
pipe/cigar in addition to cigarettes [15]. The EPIC study confirmed that pipe and cigar smoking
are related to some cancer types such as lung, bladder, and colon cancer. So far, the relation of
pipe/cigar smoking with cause-specific mortality is not as clear as that of cigarette smoking with
cause-specific mortality. For instance, Tverdal et al [16] found no or only minor differences in
the cause-specific mortality risk between pipe smokers and cigarette smokers, and reported that
both are associated with an increased risk of mortality. Another study showed that pipe/cigar
smokers have a lower risk for mortality compared with cigarette smokers [17].
We therefore aimed to examine the impact of baseline and lifetime smoking habits, lifetime
duration of smoking and duration of smoking cessation on risk of mortality due to all-cause,
CVD, COPD and any cancer and the four most common types of cancer, i.e. lung, colorectal,
prostate, and breast cancer. We used the Vlagtwedde-Vlaardingen cohort study [18,19], a pop-
ulation-based cohort with follow-up for 43 years which offered the unique possibility to inves-
tigate the impact of lifetime smoking habits on the risk of mortality. To shed more light on the
role of sex, we additionally assessed whether the association between smoking habits and mor-
tality risk is different for males and females. Other objectives of this study were to assess the
association of pipe/cigar smoking for mortality risk, and to determine which cause of death car-
ried the highest risk by performing a competing-risk analysis on mortality due to CVD, COPD,
cancer, and other causes.
Methods
Ethics statement
The Committee on Human Subjects in Research of the University Medical Center Groningen
and University of Groningen reviewed this study and affirmed the safety of the protocol and
study design. All participants gave their written informed consent.
Study population
We investigated the association between lifetime smoking habits and risk of mortality using
the Vlagtwedde-Vlaardingen cohort study. The Vlagtwedde-Vlaardingen study is a general
population based study on the epidemiology of pulmonary diseases in a general population of
exclusively white individuals of Dutch descent [18,19]. The study started in 1965, and partici-
pants had medical examinations every 3 years until the final survey in 1989/1990. In Vlaar-
dingen, only participants who were included at baseline (1965 or 1969) were approached for
follow-up, whereas in Vlagtwedde new subjects aged between 20 and 65 years were invited to
participate at every survey. The number of surveys per subject ranged from one to eight
(median number of surveys per subject: five). We updated the vital status of all participants in
the Vlagtwedde-Vlaardingen study on December 31st, 2008, and evaluated the following mor-
tality outcomes: all-cause, CVD, COPD, any cancer, and four common types of cancer i.e. lung
cancer, colorectal cancer, prostate cancer and breast cancer, either as primary or secondary
cause of death. Causes of death were coded according to the International Classification of
Lifetime Smoking History and All-Cause and Cause Specific Mortality
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Diseases (ICD) (see S1 Table for the used ICD-codes) and obtained from Statistics Netherlands
(The Hague).
Population characteristics
At all surveys, we collected data on age, sex, and smoking habits using the Dutch version of the
British Medical Research Council questionnaire [18,19]. The BMI (body mass index) was cal-
culated as weight in kilograms divided by the square of the height in meters (kg/m2).
Smoking habits at baseline
We categorized the smoking habits at baseline (i.e. the first available survey of a subject) into
three different categories:
1. Never smokers: subjects who reported never to have smoked any product (cigarettes, pipes
or cigars) during their entire life;
2. Ex-smokers: subjects who smoked one or more products but had stopped smoking at least
one month before the baseline survey;
3. Current smokers: subjects who smoked at least one cigarette a day or any other product.
Current smokers were divided into light (<10 cig/day), moderate (10–20 cig/day) and
heavy cigarette smokers (>20 cig/day) and pipe/cigar smokers (only among males). Subjects
who smoked both cigarettes and pipe/cigars were classified as cigarette smoker.
Pack-years at baseline were defined as the number of packs of cigarettes (1 pack = 20 ciga-
rettes) smoked per day in one year.
Lifetime smoking habits
Lifetime smoking habits were determined if subjects participated in at least three surveys. We
defined lifetime smoking habits within the interval between the baseline survey and the last
available survey as follows:
1. Never smokers: subjects who reported no smoking history at baseline and remained non-
smokers during the interval;
2. Ex-smokers: subjects who were ex-smokers at baseline and remained ex-smokers during the
interval;
3. Quitters: subjects who were current smokers (cigarette or pipe/cigar) at baseline but success-
fully quitted smoking and remained quitters during the interval;
4. Persistent smokers: subjects who were current smokers (cigarette or pipe/cigar) at baseline
and remained smokers during the interval. Persistent male smokers were further divided
into exclusively cigarette smokers, exclusively pipe/cigar smokers, and mixed product smok-
ers (i.e. subjects who smoked pipe/cigar one survey and cigarettes another survey);
5. Unstructured smokers which consists of the remaining subjects.
Duration of smoking and duration of smoking cessation
We calculated the duration of smoking as the difference between the age at starting smoking
and the age at last survey (for persistent smokers) or the age at quitting smoking (for ex-smok-
ers and quitters). We calculated the duration of smoking cessation as the difference between
the age at quitting smoking and the age at last survey.
Lifetime Smoking History and All-Cause and Cause Specific Mortality
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Statistical analyses
Descriptive analyses of the subject characteristics and the mortality statistics were performed.
Independent sample t-tests, Mann-Whitney U tests, or Chi-square tests were used to determine
significant differences between groups for continuous and categorical variables, respectively.
Multivariate Cox regression with adjustment for age, BMI (at baseline for the analyses on base-
line smoking habits and at last survey for all other analyses), sex, and place of residence were
used to estimate the hazard ratio of the different smoking habits on the mortality outcomes.
Since data on pipe/cigar smoking was available only in males, in the analyses on all subjects we
excluded pipe/cigar smokers. To determine whether the association between smoking habits
and mortality was different for males and females, stratified analyses were performed and inter-
actions between smoking and sex were tested. To investigate the difference between the never
smokers and all other smoking groups we used the never smokers as our reference. In addition,
in the analysis on baseline smoking habits we also performed an analysis with the ex-smokers
as the reference group in order to investigate the differences between the ex-smokers and the
current smokers. In the analysis on lifetime smoking habits we also performed an analysis with
the persistent smokers as a reference in order to investigate the differences between the persis-
tent smokers and the ex-smokers and quitters. Two separate analyses on pipe/cigar smoking at
baseline and during lifetime were performed in males only. In these analyses pipe/cigar smok-
ing was taken as the reference group. In the analyses on lifetime smoking, both duration of
smoking and duration of smoking cessation were entered in one model. To determine the time
period in which the hazard ratio after smoking cessation declines, we performed an exploratory
analysis on all-cause mortality. We divided the duration of smoking cessation in 5 categories:
1) 0 (reference group: subjects who did not quit smoking), 2)> 0–5, 3) 5–10, 4) 10–15,
and> 6) 15 years). In the Cox regression analyses censoring took place when the subjects were
still alive, were lost to follow-up, or died from a cause other than the one of interest. Cause-spe-
cific mortality was defined on both primary and secondary cause of death and the external
causes of death (i.e. suicides, homicides, traffic accidents etc.) were excluded from the analyses,
(ICD-9: codes800 and in ICD-10: codesS00). For the analyses on baseline smoking habits,
time was defined as years from baseline until mortality or until censoring. For the analyses on
lifetime smoking habits, time was defined as years from last survey until mortality or until cen-
soring. Finally, we performed a competing-risk analysis on CVD, COPD, cancer, and other
mortality [20]. All analyses were performed at Statistics Netherlands (The Hague, the Nether-
lands). P-values<0.05 (two-sided) were considered to be statistically significant.
Results
Characteristics
Characteristics of the subjects according to vital status on December 31st 2008 are presented in
Table 1. Among all 8,465 subjects, 4,505 (53.2%) were alive, 3,675 (43.4%) died due to all-
causes mortality (excluding external causes), 150 subjects (1.8%) died due to external causes
such as an accident, suicide or homicide. In 13 (0.1%) subjects the cause of death could not be
determined, and 122 (1.5%) subjects were lost to follow-up. Of those subjects who died, 1,882
(51.3%) died due to CVD, 1,194 (32.6%) died due to cancer, (147 subjects were coded for both
cancer and CVD), 366 (4.3%) died due to COPD (186 subjects were coded for both CVD and
COPD, and 83 subjects were coded for both cancer and COPD), and 380 (8.8%) died due to
another reason than CVD, COPD or cancer. Of those subjects who died due to cancer, 275
(23.0%) died due to lung cancer, 134 (11.2%) died due to colorectal cancer, 83 (7.0%) died due
to prostate cancer, and 117 (9.9%) died due to breast cancer.
Lifetime Smoking History and All-Cause and Cause Specific Mortality
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The mean age at the first survey of the subjects who died due to CVD was 50.2 (standard devi-
ation (SD) = 9.6) years, and 56.9% were males. The mean age at the first survey of the subjects
who died due to COPDwas 50.7 (SD = 9.0) years, and 76.8% were males. The mean age at the
first survey of the subjects who died due to cancer was 45.9 (SD = 11.1) years, and 58.3% were
males. Subjects who died due to cancer had significantly higher BMI levels at the first survey
compared to subjects who were alive, but had a lower BMI compared to subjects who died due to
CVD. Subjects who died due to cancer were more often heavy smokers (21.3%) compared to sub-
jects who were alive or died due to CVD or causes other than cancer (Table 1). Subjects who died
due to cancer were less often heavy smokers compared to subjects who died due to COPD.
Among all 8,465 subjects, 7,361 (87.0%) subjects had data available on baseline smoking
habits (the smoking status of this number of subjects was known, and not missing) and on all
included covariates (7,075 (83.6%) subjects had data available on cigarette smoking and 286
(3.4%) males had data available on pipe/cigar smoking). In total, 4,325 (51.1%) subjects were
ever smokers, and had data on pack-years and on all included covariates. For 3,925 (46.4%)
subjects, data on lifetime changes in smoking habits and on all included covariates could be
obtained (S2–S4 Tables).
Baseline smoking habits
Table 2 shows the hazard ratios (with 95% confidence intervals (CI)) of smoking habits at baseline
for mortality. Ex-smoking and current smoking (light, moderate, and heavy cigarette smoking)
subjects had a higher risk of all-cause, COPD, any cancer and lung cancer mortality, compared to
never smokers, the hazard ratios being highest for heavy smokers. The same pattern was observed
for mortality due to CVD. No significant associations were found between smoking habits at base-
line and risk of colorectal cancer, prostate cancer and breast cancer mortality (Table 2). The analy-
sis with the ex-smokers as the reference showed that light smoking is not associated with a higher
risk of all-cause or cause specific mortality compared to ex-smokers (S5 Table).
There was significant interaction between light, and heavy cigarette smoking and sex on risk
of mortality due to lung cancer (HR: 0.21 (0.07–0.62), and 0.29 (0.10–0.88) respectively); the
effect was more pronounced in females. There was significant interaction between moderate
cigarette smoking and sex on risk of mortality due to colorectal cancer (HR: 0.17 (0.05–0.66).
No significant interactions were observed between smoking and sex on risk of all-cause, CVD,
COPD, or any cancer mortality (Table 2).
The competing risk analyses showed that ex- and current smokers had a higher risk of
CVD, COPD, and cancer compared to all other mortality causes. In addition, heavy smokers
had a higher risk for cancer mortality compared to CVD or other causes of death, but showed a
lower risk for cancer compared to COPD mortality. In all these comparisons, COPD carried
the highest risk (S6 Table).
Within ever smokers, a higher number of pack years was associated with an increased risk
of all-cause, CVD, COPD, any and lung cancer, and prostate cancer mortality. A higher num-
ber of pack years was associated with an increased risk of colorectal cancer mortality only
among females (HR: 1.08 (95% CI: 1.04–1.11)). There were no significant associations between
pack years and risk of mortality due to breast cancer (Table 2). The numbers of pack years sig-
nificantly interacted with male sex on risk of mortality due to any cancer (HR: 0.98 (0.96–
1.00)), lung cancer (HR: 0.96 (0.94–0.99)), and colorectal cancer (HR: 0.93 (0.90–0.96)).
Lifetime (changes in) smoking habits
Table 3 shows the hazard ratio (with 95% confidence interval) of lifetime smoking habits for
mortality. Persistent cigarette smokers had a higher risk to die of all-causes, CVD, COPD, any
Lifetime Smoking History and All-Cause and Cause Specific Mortality
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cancer, and lung cancer compared to never smokers. Subjects who quitted smoking during fol-
low-up had a higher risk to die of COPD and lung cancer compared to never smokers [(HR:
2.81 (1.12–7.08), and 3.65 (95% CI: 1.32–10.10), respectively]. The analysis with the persistent
cigarette smokers as the reference showed that never smokers, persistent ex-smokers, quitters,
and unstructured smokers had a lower risk to die of all-cause, CVD, COPD, any cancer, and
lung cancer (S7 Table).
There were no significant associations between lifetime smoking habits and risk of mortality
due to colorectal cancer, prostate cancer, or breast cancer (Table 3). There were no significant
interactions between lifetime persistent cigarette smoking and sex on risk of all-cause, or cause
specific mortality. The competing risk analyses showed that lifetime persistent smokers had a
higher risk of CVD, COPD and cancer compared to other mortality causes (S8 Table). In addi-
tion, lifetime persistent smokers had a higher risk of COPD compared to cancer and CVD
mortality.
Pipe/cigar smoking
Table 4 shows the hazard ratios (with 95% confidence intervals) of smoking habits for mortal-
ity among males. Males who were never smoker at baseline had a lower risk to die of all-cause,
CVD, COPD, and any cancer compared to pipe/cigar smokers. Males who were heavy or mod-
erate smokers had a higher risk to die of all-cause, CVD, COPD, any cancer, and lung cancer
compared to pipe/cigar smokers. Lifetime persistent ex-smokers had a lower risk to die of lung
cancer compared to pipe/cigar smokers HR: 0.12 (95% CI: 0.03–0.55).
Lifetime duration of smoking and duration of smoking cessation
A longer lifetime duration of smoking was associated with a higher risk of mortality from, any
cancer and from lung cancer [(any cancer: HR: 1.03 (95% CI: 1.00–1.06), and lung cancer: HR:
1.10 (95% CI: 1.03–1.17)], but not with other causes of death (Table 5). There was a significant
interaction between duration of smoking and sex on the risk of mortality due to colorectal can-
cer (HR: 0.91 (0.83–0.99)); the effect was stronger in females. (Table 5).
Discussion
In this cohort study we investigated the impact of baseline cigarette and pipe/cigar smoking,
pack-years, and lifetime smoking history on the relative risk of all-cause and cause-specific
mortality (i.e. CVD, COPD and cancer mortality) in both sexes. Current smoking (light, mod-
erate, and heavy cigarette), and lifetime persistent smoking were associated with an increased
risk of all-cause, CVD, COPD, any cancer and lung cancer mortality. A higher number of pack
years at baseline was associated with an increased risk of all-cause, CVD, COPD, any cancer,
lung cancer and prostate cancer mortality. The effect of smoking on the risk of lung cancer
mortality was different for males and females; the effect was more pronounced in females.
Moreover, significant interactions between light cigarette smoking and sex, and pack years and
sex on risk of mortality due to lung cancer were observed. A longer duration of smoking was
associated with an increased risk of mortality due to COPD, any cancer and lung cancer, but
not with other causes of death. A longer duration of smoking cessation was associated with a
decreased risk of all-cause and CVDmortality. In the competing risk analyses, smoking had
the highest association with COPD mortality compared to CVD, cancer, and the other mortal-
ity causes. In addition, ex- and current smokers had a higher risk of CVD and cancer compared
to all other mortality causes, and heavy smokers had a higher risk for cancer mortality com-
pared to CVD.
Lifetime Smoking History and All-Cause and Cause Specific Mortality
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Our results are in line with the conclusion of the recent review by IARC [8], and other stud-
ies [11,21]. In addition, it helps to expand and clarify the links between smoking and common
types of cancer and other causes of mortality in both sexes.
Among the smoking-associated case-specific mortality in our study, COPD had the highest
risk. Our results for COPD is in line with the results of a previous study (11), in which authors
used competing risks survival analysis to evaluate the associations between smoking and all-
cause and cause-specific mortality. Authors reported that the smoking-attributed Hazart Ratios
for COPD and lung cancer mortality are much higher than the HRs for total mortality (11).
Lung cancer has been clearly linked to smoking [22,23]. However, there is still a need for
more researches to clarify the impact of lifetime smoking habits such as duration of smoking
and duration of smoking cessation on lung cancer mortality. We found that longer lifetime
duration of cigarette smoking is associated with an increased risk of lung cancer mortality
among persistent smokers, ex-smokers and quitters. We found no significant association
between duration of smoking cessation and risk of mortality due to lung cancer; however, a
negative trend was observed. In contrast, the majority of previous studies showed a clear nega-
tive association between smoking cessation and lung cancer. Evidence suggests that this associ-
ation varies by histologic cell type [24,25]. An increased duration of smoking cessation has
been linked to a decreased risk of small cell and squamous cell carcinoma but not with adeno-
carcinoma [24,25]. Apart from the role of histologic cell type in this association, the time that
needs to pass before the risk of lung cancer among quitters reaches that of never smokers is less
clear. Bosse et al [25] investigated the effect of smoking cessation on the molecular signature of
smoking in lung tissues and showed that smokers who quitted more recently have the same
gene-expression profile as current smokers, while over time this profile appears to change into
the profile of never smokers. However, the mechanism underlying this association is still
unclear and warrants further studies.
One objective of our study was to investigate the potential effect modification of sex on the
association between smoking and cause-specific mortality. Our results confirm the hypothesis
by Henschke et al [26] that females may be more susceptible to develop lung cancer than
males. However, there are also studies showing a higher susceptibility among males [5]. A sys-
tematic review and meta-analysis of the epidemiological evidence on the association between
lung cancer and smoking showed that the relative risks for smoking tended to be higher for
males compared to females. [5]. However, the authors suggested this does not necessarily
reflect a higher susceptibility for males, since it could also reflect a higher exposure to occupa-
tional carcinogens and a different smoking history (e.g, longer smoking duration) in males [5].
Additionally, we observed that the effect of moderate and heavy smoking compared to ex-
smoking on risk of all-cause mortality was more pronounced in females than in males. This
may suggest that quitting smoking is more beneficial for females than males in term of lung
cancer as well as all-cause mortality. However, a number of questions remain to be answered.
For instance, it is still unclear whether the same extent of exposure (number of smoked ciga-
rettes, duration of smoking, and depth of inhalation) carries similar risks in males and females
for cause-specific mortality.
Breast cancer mortality was not associated with baseline and lifetime smoking habits, dura-
tion of smoking, or duration of smoking cessation. Whether there is an association between
smoking and breast cancer remains debated. While the majority of studies reported no associa-
tion, some studies suggested that this association is limited to pre-menopausal breast cancer
and estrogen receptor positive breast cancer [27–33]. Several mechanisms have been proposed
for possible protective or carcinogenic effects of cigarette smoking on breast cancer incidence
[28–32]. A high level of estrogen is associated with an increased risk of breast carcinogenesis
[31], and smoking has an anti-estrogenic capacity. Therefore, one of the proposed mechanisms
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is that cigarette smoking decreases the risk of breast cancer through this “anti-estrogenic”
mechanism. Smoking may enhance the metabolism of estradiol, increase the binding of estro-
gens by serum sex hormone-binding globulin, and lower the levels of estrogen derived from
adipose tissue [32] thus leading to a decreased risk of breast cancer. However, as mentioned
earlier, smoking has also been linked to an increased risk of breast cancer [31]. Furthermore,
the European Prospective Investigation into Cancer (EPIC) study on the association between
smoking and breast cancer suggested that passive smoke exposure also plays a role in this.
They reported that the risk estimates of active smoking for breast cancer were higher when the
reference group consisted of never smokers who were also not exposed to passive smoke, com-
pared to when passive smoking was not taken into account [33]. There are also suggestions
that the association between smoking and breast cancer could be confounded by alcohol. A col-
laborative reanalysis of individual data from 53 epidemiological studies showed that ever-
smokers and current smokers did not have an increased risk of breast cancer compared to
never-smokers among women who reported no alcohol consumption [34].
Apart from the above mentioned factors that can affect the link between smoking and can-
cer, it has been hypothesized that genetic variants in enzymes involved in the metabolism of
carcinogens may also play a role in this link. Cigarette smoke contains many carcinogens such
as polycyclic aromatic hydrocarbons, nitrosamines, and heterocyclic amines. In particular, the
fact that susceptibility to these carcinogens may differ widely among individuals due to genetic
variation may explain the observed discrepancy of results among studies. This suggests that the
findings from one population for the link between smoking and cancer may not be easily gen-
eralizable to another population [33].
Our findings regarding mortality due to CVD are in line with several other studies that
reported that smoking is associated with increased risk of mortality due to CVD [1,3]. Interest-
ingly, subjects who quitted smoking during follow-up had no increased risk of mortality due to
CVD compared to never smokers. In line with our finding, the majority of previous studies
show that after smoking cessation, the risk of CVDmortality declines [35, 36]. This can be
explained by the fact that the inflammatory component of CVD resulting from smoking is
reversible after smoking cessation [35]. However, the time that needs to pass before the risk of
CVDmortality among ex-smokers reaches that of never smokers is less clear. In addition, the
level to which the inflammatory response declines after smoking cessation has not been subject
of many studies. Therefore more studies are needed on the impact of smoking cessation regard-
ing the risk of CVD mortality as well as other causes of death.
One of our interesting findings regarding the all-cause mortality is that the hazard ratio
after smoking cessation declined in the first 5 years after quitting and this effect was not
observed any further with a longer duration of smoking cessation. Our in depth analyses
showed that at least 3 years is needed to pass before the risk of all-cause mortality declines
among ex-smokers (results not shown). However, due to the small sample size our results need
to be interpreted with caution.
Our analyses including pipe/cigar smokers among males revealed that heavy cigarette smok-
ing at baseline was associated with an increased risk of all-cause mortality, and mortality due to
CVD, any cancer, and lung cancer compared to pipe/cigar smokers. Contrary to the baseline
findings, lifetime persistent cigarette smoking was not significantly associated with a higher
risk of all-cause or cause-specific mortality compared to pipe/cigar smoking.
Higher concentrations of nitrosamines, which are associated with an increased risk of can-
cer, are found in pipe/cigar smoke than in cigarette smoke [15–17]. Previous studies [12, 15,
35] suggest that switching to pipe/cigar smoking is not a safe alternative for cigarette smokers
to reduce the risk of cancer. Shaper et al [37] investigated the impact of pipe/cigar smoking on
all-cause mortality, cancer, and CVD and reported that both pipe/cigar smoking and mixed
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product smoking was associated with an increased risk of all-cause mortality, cancer incidence,
and CVD compared to never smoking. Unfortunately, Shaper et al. did not address lifetime
impact of (changes in) pipe/cigar smoking. Given the fact that the types of cigars varies among
countries (e.g., different sizes, filters and packaging) more studies are needed to address the
detailed information on the types of cigars and the depth of inhalation and to clarify the associ-
ation between cigar-smoking and cause-specific mortality [38].
One objective of our study was to use competing risk survival analysis to evaluate the impact
of baseline and lifetime smoking on causes-specific mortality simultaneously. One of our inter-
esting findings was that heavy smokers had a significantly higher risk to die of cancer than to
die of CVD among all subjects, while this pattern was not significant among males.
The major strength of our current study is the longitudinal design. We were able to follow
our participants for 43 years, which provided a unique wide time window for evaluating the
impact of lifetime (changes in) smoking habits on cause-specific mortality. Another strength of
our study is the high follow-up rate, since 98.5% of the included subjects could be traced back
[39]. We studied the association between smoking and all-cause, CVD, COPD, and cancer
mortality in four common types of cancer (lung cancer, colorectal cancer, prostate cancer and
breast cancer), while previous studies investigated overall mortality or any cancer mortality, or
only one specific cause of death.
The lack of information on alcohol consumption, inhalation patterns (e.g., depth of inhalation
and smoke holding), and menopause status of females may be considered a limitation in our
study. Evidence shows that the menopause status of females may modify the effect of smoking on
risk of cause-specific mortality [11]. Another drawback of our study is that subjects were not
asked about passive exposure to tobacco smoke. Therefore it is possible that some passive smok-
ers were incorrectly classified as unexposed (never smokers). Finally, subjects who smoked both
cigarettes and pipe/cigars at baseline were coded as a cigarette smoker in our study. Therefore,
the impact of baseline mixed smokers on mortality risk could not be investigated.
In summary, our findings, by addressing the impact of lifetime smoking habits in both
sexes, corroborate and expand the ideas of Kenfield et al [11], who, in a study of females, found
stronger associations between smoking and mortality when using updated smoking status dur-
ing follow-up compared to baseline measurements, suggesting that many of the previous stud-
ies may have underestimated the risk of mortality due to smoking by considering only single
measurements (i.e. at baseline).
In addition, our study suggests that the impact of lifetime cigarette, pipe/cigar smoking and
duration of smoking vary for different causes of death, and that smoking cessation is effective
to reduce the risk of all-cause mortality.
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